Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors in NSCLC: Two Heads Are Better Than One

被引：0

作者：

Shih, Jin-Yuan ^{[1
,2
,3
,4
]}

Lin, Yen -Ting ^{[1
,2
,3
]}

机构：

[1] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan

[2] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, 7 Zhongshan South Rd, Taipei 100, Taiwan

[3] Natl Taiwan Univ, Coll Med, 7 Zhongshan South Rd, Taipei 100, Taiwan

[4] Natl Taiwan Univ, Canc Ctr, Dept Med, Taipei, Taiwan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 02期

关键词：

SPECIFIED FINAL ANALYSIS; NIVOLUMAB; PEMBROLIZUMAB; CHEMOTHERAPY; DOCETAXEL;

D O I：

10.1016/j.jtho.2021.11.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：176 / 178

页数：3

共 13 条

[1] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[2] Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study [J].

Boyer, Michael ;

Sendur, Mehmet A. N. ;

Rodriguez-Abreu, Delvys ;

Park, Keunchil ;

Lee, Dae Ho ;

Cicin, Irfan ;

Yumuk, Perran Fulden ;

Orlandi, Francisco J. ;

Leal, Ticiana A. ;

Molinier, Olivier ;

Soparattanapaisarn, Nopadol ;

Langleben, Adrian ;

Califano, Raffaele ;

Medgyasszay, Balazs ;

Hsia, Te-Chun ;

Otterson, Gregory A. ;

Xu, Lu ;

Piperdi, Bilal ;

Samkari, Ayman ;

Reck, Martin .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (21) :2327-+

[3] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].

Brahmer, Julie ;

Reckamp, Karen L. ;

Baas, Paul ;

Crino, Lucio ;

Eberhardt, Wilfried E. E. ;

Poddubskaya, Elena ;

Antonia, Scott ;

Pluzanski, Adam ;

Vokes, Everett E. ;

Holgado, Esther ;

Waterhouse, David ;

Ready, Neal ;

Gainor, Justin ;

Aren Frontera, Osvaldo ;

Havel, Libor ;

Steins, Martin ;

Garassino, Marina C. ;

Aerts, Joachim G. ;

Domine, Manuel ;

Paz-Ares, Luis ;

Reck, Martin ;

Baudelet, Christine ;

Harbison, Christopher T. ;

Lestini, Brian ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135

[4] Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis [J].

Fan, Yong ;

Xie, Wenhui ;

Huang, Hong ;

Wang, Yunxia ;

Li, Guangtao ;

Geng, Yan ;

Hao, Yanjie ;

Zhang, Zhuoli .

FRONTIERS IN ONCOLOGY, 2021, 11

[5] Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer [J].

Hellmann, M. D. ;

Paz-Ares, L. ;

Bernabe Caro, R. ;

Zurawski, B. ;

Kim, S. -W. ;

Carcereny Costa, E. ;

Park, K. ;

Alexandru, A. ;

Lupinacci, L. ;

de la Mora Jimenez, E. ;

Sakai, H. ;

Albert, I. ;

Vergnenegre, A. ;

Peters, S. ;

Syrigos, K. ;

Barlesi, F. ;

Reck, M. ;

Borghaei, H. ;

Brahmer, J. R. ;

O'Byrne, K. J. ;

Geese, W. J. ;

Bhagavatheeswaran, P. ;

Rabindran, S. K. ;

Kasinathan, R. S. ;

Nathan, F. E. ;

Ramalingam, S. S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) :2020-2031

[6] Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden [J].

Hellmann, M. D. ;

Ciuleanu, T. -E. ;

Pluzanski, A. ;

Lee, J. S. ;

Otterson, G. A. ;

Audigier-Valette, C. ;

Minenza, E. ;

Linardou, H. ;

Burgers, S. ;

Salman, P. ;

Borghaei, H. ;

Ramalingam, S. S. ;

Brahmer, J. ;

Reck, M. ;

O'Byrne, K. J. ;

Geese, W. J. ;

Green, G. ;

Chang, H. ;

Szustakowski, J. ;

Bhagavatheeswaran, P. ;

Healey, D. ;

Fu, Y. ;

Nathan, F. ;

Paz-Ares, L. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22) :2093-2104

[7] Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance [J].

Kiyohara, Yoshio ;

Uhara, Hisashi ;

Ito, Yoshihiko ;

Matsumoto, Noritake ;

Tsuchida, Tetsuya ;

Yamazaki, Naoya .

JOURNAL OF DERMATOLOGY, 2018, 45 (04) :408-415

[8]

Paz-Ares L., 2019, ANN ONCOL, V30, pxi67, DOI DOI 10.1093/ANNONC/MDZ453.004

[9] A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407 [J].

Paz-Ares, Luis ;

Vicente, David ;

Tafreshi, Ali ;

Robinson, Andrew ;

Parra, Hector Soto ;

Mazieres, Julien ;

Hermes, Barbara ;

Cicin, Irfan ;

Medgyasszay, Balazs ;

Rodriguez-Cid, Jeronimo ;

Okamoto, Isamu ;

Lee, SungSook ;

Ramlau, Rodryg ;

Vladimirov, Vladimir ;

Cheng, Ying ;

Deng, Xuan ;

Zhang, Ying ;

Bas, Tuba ;

Piperdi, Bilal ;

Halmos, Balazs .

JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (10) :1657-1669

[10] First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial [J].

Paz-Ares, Luis G. ;

Ramalingam, Suresh S. ;

Ciuleanu, Tudor-Eliade ;

Lee, Jong-Seok ;

Urban, Laszlo ;

Caro, Reyes Bernabe ;

Park, Keunchil ;

Sakai, Hiroshi ;

Ohe, Yuichiro ;

Nishio, Makoto ;

Audigier-Valette, Clarisse ;

Burgers, Jacobus A. ;

Pluzanski, Adam ;

Sangha, Randeep ;

Gallardo, Carlos ;

Takeda, Masayuki ;

Linardou, Helena ;

Lupinacci, Lorena ;

Lee, Ki Hyeong ;

Caserta, Claudia ;

Provencio, Mariano ;

Carcereny, Enric ;

Otterson, Gregory A. ;

Schenker, Michael ;

Zurawski, Bogdan ;

Alexandru, Aurelia ;

Vergnenegre, Alain ;

Raimbourg, Judith ;

Feeney, Kynan ;

Kim, Sang-We ;

Borghaei, Hossein ;

O'Byrne, Kenneth John ;

Hellmann, Matthew D. ;

Memaj, Arteid ;

Nathan, Faith Ellen ;

Bushong, Judith ;

Phuong Tran ;

Brahmer, Julie R. ;

Reck, Martin .

JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (02) :289-308

← 1 2 →